Cobalt Pharmaceuticals

Cobalt Pharmaceuticals was a prominent Canadian pharmaceutical company specializing in the development, manufacturing, and distribution of generic drug products. Headquartered in Mississauga, Ontario, the company established a significant presence in the Canadian healthcare market by providing high-quality, cost-effective alternatives to brand-name medications across various therapeutic areas, including cardiology and neurology. In 2009, Cobalt was acquired by Watson Pharmaceuticals as part of its $1.75 billion acquisition of the Arrow Group. Following subsequent industry consolidations involving Actavis and Allergan, the business was eventually integrated into Teva Pharmaceutical Industries. Today, the legacy of Cobalt's operations continues as part of Teva Canada's generic pharmaceutical portfolio.